NewEdge Wealth LLC Trims Stock Position in Chemed Corporation $CHE

NewEdge Wealth LLC cut its holdings in shares of Chemed Corporation (NYSE:CHE) by 25.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 4,221 shares of the company’s stock after selling 1,444 shares during the quarter. NewEdge Wealth LLC’s holdings in Chemed were worth $1,806,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC lifted its position in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the period. First Horizon Corp purchased a new position in Chemed during the third quarter worth about $31,000. Pilgrim Partners Asia Pte Ltd purchased a new position in Chemed during the third quarter worth about $45,000. Danske Bank A S lifted its position in Chemed by 250.0% during the fourth quarter. Danske Bank A S now owns 140 shares of the company’s stock worth $60,000 after buying an additional 100 shares during the period. Finally, Geneos Wealth Management Inc. lifted its position in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares in the company, valued at $37,993,927.47. This trade represents a 2.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 3.33% of the stock is currently owned by company insiders.

Chemed Price Performance

CHE stock opened at $422.71 on Thursday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $583.96. The firm has a market cap of $5.61 billion, a P/E ratio of 23.04, a price-to-earnings-growth ratio of 1.57 and a beta of 0.54. The stock has a 50-day simple moving average of $396.27 and a 200-day simple moving average of $425.23.

Chemed (NYSE:CHE) last posted its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. During the same quarter last year, the firm earned $5.63 earnings per share. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities analysts predict that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were paid a $0.60 dividend. The ex-dividend date was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 13.08%.

Wall Street Analyst Weigh In

CHE has been the topic of several recent analyst reports. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Oppenheimer reduced their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Finally, Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $501.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.